Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007WO2007120930A2 Stable pharmaceutical compositions of 2-aza-bicyclo[3.3.0]-octane-3-carboxylic acid derivatives
10/25/2007WO2007120897A2 Compositions and intraluminal devices for inhibiting vascular stenosis
10/25/2007WO2007120883A2 Compositions and their uses directed to hepcidin
10/25/2007WO2007120868A2 Bioavailability enhancement of lipophilic drug by use solvent system
10/25/2007WO2007120864A2 Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
10/25/2007WO2007120842A2 Methods and compositions for targeting c-rel
10/25/2007WO2007120839A2 C-nitroso-derived nitroxyl donors
10/25/2007WO2007120827A2 Use of biarylcarboxamides in the treatment of hedgehog pathway-related disorders
10/25/2007WO2007120817A2 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear
10/25/2007WO2007120815A2 Methods for treating lymphocyte-associated disorders by modulation of siglec activity
10/25/2007WO2007120768A1 Oral patch with salt of glycyrrhetinic acid water soluble at human mouth temperatures
10/25/2007WO2007120760A2 Thiophene-carboxamides useful as inhibitors of protein kinases
10/25/2007WO2007120730A2 Fused ring thrombin receptor antagonists
10/25/2007WO2007120729A2 Pyridyl amide t-type calcium channel antagonists
10/25/2007WO2007120726A2 Compositions and methods related to rad51 inactivation in the treatment of neoplastic diseases, and especially cml
10/25/2007WO2007120718A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007WO2007120702A2 Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto
10/25/2007WO2007120690A2 Combination histamine h1r and h4r antagonist therapy for treating pruritus
10/25/2007WO2007120688A2 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
10/25/2007WO2007120665A2 Formulation and method for a skin treatment for animals
10/25/2007WO2007120621A2 Nonel 1,2,3,4-tetrahydroquinoline derivatives
10/25/2007WO2007120606A2 Methods for modulating formation and progression of cellulite
10/25/2007WO2007120605A2 Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists
10/25/2007WO2007120600A2 3-pyridinyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
10/25/2007WO2007120599A2 Dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/25/2007WO2007120596A1 DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS
10/25/2007WO2007120595A2 Amines for the treatment of hcv
10/25/2007WO2007120594A1 Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
10/25/2007WO2007120593A1 Anilino-pyrimidine phenyl and benzothiophene analogs
10/25/2007WO2007120592A1 Cgrp antagonist salt
10/25/2007WO2007120574A2 Diaryl substituted alkanes
10/25/2007WO2007120555A2 Assessment of heart failure risk using genetic assessment of g-protein beta-3 subunit polymorphism
10/25/2007WO2007120544A2 Compositions comprising pyruvate alkyl esters and uses thereof
10/25/2007WO2007120523A2 6-(aminoalkyl)indazoles
10/25/2007WO2007120485A2 Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor
10/25/2007WO2007120484A2 Use of inositol-tripyrophosphate in treating tumors and diseases
10/25/2007WO2007120454A1 Azolopyrimidines as inhibitors of cannabinoid 1 activity
10/25/2007WO2007120445A1 SOLUBLE SALTS OF THIENO [2,3-d] PYRIMIDINE DERIVATIVES
10/25/2007WO2007120385A2 Low flush niacin formulation
10/25/2007WO2007120379A2 Sulfonanilide analogs as selective aromatase modulators
10/25/2007WO2007120374A2 Anti-arenaviral compounds
10/25/2007WO2007120364A2 Metabolites of wortmannin analogs and methods of using the same
10/25/2007WO2007120343A2 Heat shock rna and its use
10/25/2007WO2007120339A1 Pyrimidine kinase inhibitors
10/25/2007WO2007120333A2 Tetracyclic kinase inhibitors
10/25/2007WO2007120284A2 Glucagon receptor antagonists, preparation and therapeutic uses
10/25/2007WO2007120263A2 Preparation of dutasteride
10/25/2007WO2007120170A2 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/25/2007WO2007120160A2 Lactam containing hcv inhibitors
10/25/2007WO2007120121A2 Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
10/25/2007WO2007120102A1 New substituted oxindole derivatives
10/25/2007WO2007120101A1 Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
10/25/2007WO2007120098A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007WO2007120097A1 Thioxanthine derivatives and their use as inhibitors of mpo
10/25/2007WO2007120096A1 Thiazol-guanidine derivatives useful as a (beta)- related pathologies
10/25/2007WO2007120083A1 The use of carboxamide derivatives in the manufacture of a medicament for the treatment of inflammatory, allergic and dermatological conditions
10/25/2007WO2007119973A1 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
10/25/2007WO2007119959A1 Composition isolated from puerariae radix for prevention or treatment of diabetic complications and a separation method thereof
10/25/2007WO2007119889A1 Novel piperazine compound, and use thereof as hcv polymerase inhibitor
10/25/2007WO2007119887A1 ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ
10/25/2007WO2007119837A1 Lipase inhibitor
10/25/2007WO2007119833A1 Nitrogen-containing heterocyclic compound
10/25/2007WO2007119815A1 Toll-like receptor 9 agonists
10/25/2007WO2007119799A1 Marker for detecting myocardial differentiation activity of cell
10/25/2007WO2007119792A1 Dry direct compression fast disintegrating tablet
10/25/2007WO2007119754A1 Agent for prevention or treatment of leukemia and beverage/food
10/25/2007WO2007119692A1 METHOD OF INHIBITING CANCER CELL PROLIFERATION BY REGULATING eIF4H EXPRESSION
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119656A1 Tamsulosin-containing percutaneous absorption type preparation
10/25/2007WO2007119624A1 Nucleoside derivative having antiherpesvirus activity
10/25/2007WO2007119601A2 Nanoparticles comprising a pdgf receptor tyrosine kinase inhibitor
10/25/2007WO2007119600A1 Carbazole compound
10/25/2007WO2007119588A1 Brain function-improving agent, and functional food containing the improving agent
10/25/2007WO2007119578A1 Agent for improving nervous system cell functions
10/25/2007WO2007119564A1 siRNA SPECIFIC TO WT1 17AA(-)ISOFORM AND USE THEREOF
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119511A1 Cephem compounds and use as antimicrobial agents
10/25/2007WO2007119496A1 Tetomilast polymorphs
10/25/2007WO2007119486A1 Liquid composition for external application and preparation for external application for treatment of skin ulcer
10/25/2007WO2007119463A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
10/25/2007WO2007119378A1 Composition containing riboflavin and sesamins
10/25/2007WO2007119367A1 Composition containing biopterin and method for using the same
10/25/2007WO2007119248A1 A novel crystalline form of lamivudine
10/25/2007WO2007119214A2 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
10/25/2007WO2007119193A2 Personalizing communications layer
10/25/2007WO2007119177A2 Modified release formulations and methods of treating inflammatory bowel disease
10/25/2007WO2007119151A1 Treatment of menopause-associated symptoms
10/25/2007WO2007119110A2 Process for the preparation of tamsulosin and related compounds
10/25/2007WO2007119109A2 Processes for preparing tegaserod maleate and pharmaceutical compositions containing it
10/25/2007WO2007119108A2 Inositol derivatives and their uses in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
10/25/2007WO2007119098A2 Use of an nmda receptor antagonist the treatment of tinnitus induced by cochlear excitotoxicity
10/25/2007WO2007119085A1 Rosuvastatin zinc salt
10/25/2007WO2007119055A1 Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
10/25/2007WO2007119046A1 4-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitors
10/25/2007WO2007119028A2 Composition including at least one aqueous phase and at least one fatty phase including ivermectin
10/25/2007WO2007119027A1 Calixarene derivatives as anticancer agent
10/25/2007WO2007119006A1 New medicines for treatments against retroviruses
10/25/2007WO2007118996A2 Use of at least one cytosolic phospholipase a2 inhibitor as a medicine for symptomatic treatment of mucoviscidosis
10/25/2007WO2007118984A1 Use of (s)-roscovitine for manufacturing a medicine
10/25/2007WO2007118979A1 Type 5 and type 8 capsular polysaccharides of superproducing staphylococcus aureus strains
1 ... 3527 3528 3529 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 ... 7860